<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04871971</url>
  </required_header>
  <id_info>
    <org_study_id>CPS-20-255</org_study_id>
    <secondary_id>WT762123</secondary_id>
    <nct_id>NCT04871971</nct_id>
  </id_info>
  <brief_title>Glycaemic Response and Insulinaemic Response for Nutralys S85 Plus and Whey Protein</brief_title>
  <official_title>Glycaemic Response and Insulinaemic Response for Nutralys S85 Plus and Whey Protein</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oxford Brookes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Roquette Freres</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Oxford Brookes University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A comparison of the glycaemic response and insulinaemic response to glucose, Nutralys S85&#xD;
      Plus pea protein and whey protein using a single-blind, randomised, repeat measure, crossover&#xD;
      design trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single-blind, randomised, repeat measure, crossover design trial will be used to study the&#xD;
      glycaemic response and insulinaemic response following consumption of five products: one&#xD;
      reference product (50 g available carbohydrate Glucose) and four test products (50 g&#xD;
      available carbohydrate Glucose with 10 g NUTRALYS®S85 Plus pea protein, 50 g available&#xD;
      carbohydrate Glucose with 20 g NUTRALYS®S85 Plus pea protein, 50 g available carbohydrate&#xD;
      Glucose with 10 g Whey protein concentrate and 50 g available carbohydrate Glucose with 20 g&#xD;
      Whey protein concentrate).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>single-blind, randomised, repeat measure, crossover design trial</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>single-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood glucose response from baseline for 3 hours</measure>
    <time_frame>3 hours</time_frame>
    <description>Change in postprandial blood glucose response from baseline was measured at 15 min, 30 min, 45 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours and 3 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in plasma insulin response from baseline for 3 hours</measure>
    <time_frame>3 hours</time_frame>
    <description>Change in postprandial plasma insulin response from baseline was measured at 15 min, 30 min, 45 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours and 3 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the blood glucose concentration versus time curve</measure>
    <time_frame>3 hours</time_frame>
    <description>Area under the blood glucose concentration versus time curve was calculated by trapezoidal rule</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the plasma insulin concentration versus time curve</measure>
    <time_frame>3 hours</time_frame>
    <description>Area under the plasma insulin concentration versus time curve was calculated by trapezoidal rule</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak blood glucose concentration (Cmax)</measure>
    <time_frame>0-3 hours</time_frame>
    <description>Peak blood glucose concentration (Cmax) after consumption of the test food</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak plasma insulin concentration (Cmax)</measure>
    <time_frame>0-3 hours</time_frame>
    <description>Peak plasma insulin concentration (Cmax) after consumption of the test food</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of blood glucose peak (Tmax)</measure>
    <time_frame>0-3 hours</time_frame>
    <description>Time of blood glucose peak after consumption of the test food</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of plasma insulin peak (Tmax)</measure>
    <time_frame>0-3 hours</time_frame>
    <description>Time of plasma insulin peak after consumption of the test food</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Glucose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Glucose 50 g available carbohydrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 g NUTRALYS®S85 Plus pea protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 g available carbohydrate Glucose + 10 g NUTRALYS®S85 Plus pea protein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20 g NUTRALYS®S85 Plus pea protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 g available carbohydrate Glucose + 20 g NUTRALYS®S85 Plus pea protein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 g Whey protein concentrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 g available carbohydrate Glucose + 10 g Whey protein concentrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20 g Whey protein concentrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 g available carbohydrate Glucose + 20 g Whey protein concentrate</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>10 g NUTRALYS®S85 Plus pea protein</intervention_name>
    <description>To determine the glycaemic response and insulinaemic response to 50g Glucose + 10 g NUTRALYS®S85 Plus pea protein.</description>
    <arm_group_label>10 g NUTRALYS®S85 Plus pea protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>20 g NUTRALYS®S85 Plus pea protein</intervention_name>
    <description>To determine the glycaemic response and insulinaemic response to 50g Glucose + 20 g NUTRALYS®S85 Plus pea protein.</description>
    <arm_group_label>20 g NUTRALYS®S85 Plus pea protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>10 g Whey protein concentrate</intervention_name>
    <description>To determine the glycaemic response and insulinaemic response to 50g Glucose + 10 g Whey protein concentrate.</description>
    <arm_group_label>10 g Whey protein concentrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>20 g Whey protein concentrate</intervention_name>
    <description>To determine the glycaemic response and insulinaemic response to 50g Glucose + 20 g Whey protein concentrate.</description>
    <arm_group_label>20 g Whey protein concentrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>50 g Glucose</intervention_name>
    <description>To determine the glycaemic response and insulinaemic response to 50g Glucose</description>
    <arm_group_label>Glucose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 to 60 years&#xD;
&#xD;
          -  Body mass index (BMI) less than 30kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Fasting blood glucose value &gt; 6.1 mmol/l&#xD;
&#xD;
          -  Any known food allergy or intolerance&#xD;
&#xD;
          -  Medical condition(s) or medication(s) known to affect glucose regulation or appetite&#xD;
             and/or which influence digestion and absorption of nutrients&#xD;
&#xD;
          -  Known history of diabetes mellitus or the use of antihyperglycaemic drugs or insulin&#xD;
             to treat diabetes and related conditions&#xD;
&#xD;
          -  Major medical or surgical event requiring hospitalization within the preceding 3&#xD;
             months&#xD;
&#xD;
          -  Use of steroids, protease inhibitors or antipsychotics (all of which have major&#xD;
             effects on glucose metabolism and body fat distribution)&#xD;
&#xD;
          -  Unable to comply with experimental procedures or did not follow GR testing safety&#xD;
             guidelines.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sangeetha Thondre, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oxford Brookes University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sangeetha Thondre, PhD</last_name>
    <phone>00-44-1865483988</phone>
    <email>pthondre@brookes.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabel Butler, MSc</last_name>
    <phone>00-44-1865 483297</phone>
    <email>ibutler@brookes.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oxford Brookes Centre for Nutrition and Health</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 0BP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sangeetha Thondre, PhD</last_name>
      <phone>01865483988</phone>
      <email>pthondre@brookes.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Isabel Butler</last_name>
      <email>ibutler@brookes.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.iso.org/standard/43633.html</url>
    <description>Food Products-Determination of the glycaemic index (GI) and recommendation for food classification.</description>
  </link>
  <reference>
    <citation>Siahanidou T, Margeli A, Kappis A, Papassotiriou I, Mandyla H. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids. Metabolism. 2011 Mar;60(3):389-93. doi: 10.1016/j.metabol.2010.03.002. Epub 2010 Mar 31.</citation>
    <PMID>20359723</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oxford Brookes University</investigator_affiliation>
    <investigator_full_name>Dr. Sangeetha Thondre</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 25, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT04871971/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

